Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Andrea Aroldi"'
Autor:
Diletta Fontana, Ilaria Crespiatico, Valentina Crippa, Federica Malighetti, Matteo Villa, Fabrizio Angaroni, Luca De Sano, Andrea Aroldi, Marco Antoniotti, Giulio Caravagna, Rocco Piazza, Alex Graudenzi, Luca Mologni, Daniele Ramazzotti
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-18 (2023)
Abstract Recurring sequences of genomic alterations occurring across patients can highlight repeated evolutionary processes with significant implications for predicting cancer progression. Leveraging the ever-increasing availability of cancer omics d
Externí odkaz:
https://doaj.org/article/2c8ebc0ac2384c04920b0f140fda5e6f
Autor:
Elisa Bossi, Andrea Aroldi, Lorenza Maria Borin, Luisa Verga, Diletta Fontana, Federica Cocito, Beatrice Manghisi, Giovanni Rindone, Fabrizio Cavalca, Alessia Ripamonti, Monica Raggi, Sergio Maria Ivano Malandrin, Annalisa Cavallero, Laura Antolini, Diego Bonardi, Rocco Giovanni Piazza, Carlo Gambacorti‐Passerini
Publikováno v:
eJHaem, Vol 3, Iss 4, Pp 1201-1208 (2022)
Abstract Hematological patients at higher risk of severe COVID‐19 were excluded from the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccine trials. In this single‐center observational prospective study (NCT05074706), we eval
Externí odkaz:
https://doaj.org/article/06951e00598a49aea08643eef208508c
Autor:
Andrea Aroldi, Fabrizio Angaroni, Deborah D’Aliberti, Silvia Spinelli, Ilaria Crespiatico, Valentina Crippa, Rocco Piazza, Alex Graudenzi, Daniele Ramazzotti
Publikováno v:
Viruses, Vol 15, Iss 1, p 7 (2022)
We present a large-scale analysis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) substitutions, considering 1,585,456 high-quality raw sequencing samples, aimed at investigating the existence and quantifying the effect of mutational
Externí odkaz:
https://doaj.org/article/bee606511a6c4a0f9e23d73f0369d467
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia
Autor:
Diletta Fontana, Daniele Ramazzotti, Andrea Aroldi, Sara Redaelli, Vera Magistroni, Alessandra Pirola, Antonio Niro, Luca Massimino, Cristina Mastini, Virginia Brambilla, Silvia Bombelli, Silvia Bungaro, Alessandro Morotti, Delphine Rea, Fabio Stagno, Bruno Martino, Leonardo Campiotti, Giovanni Caocci, Emilio Usala, Michele Merli, Francesco Onida, Marco Bregni, Elena Maria Elli, Monica Fumagalli, Fabio Ciceri, Roberto A. Perego, Fabio Pagni, Luca Mologni, Rocco Piazza, Carlo Gambacorti-Passerini
Publikováno v:
HemaSphere, Vol 4, Iss 6, p e497 (2020)
Abstract. Atypical chronic myeloid leukemia (aCML) is a BCR-ABL1-negative clonal disorder, which belongs to the myelodysplastic/myeloproliferative group. This disease is characterized by recurrent somatic mutations in SETBP1, ASXL1 and ETNK1 genes, a
Externí odkaz:
https://doaj.org/article/3319347f08c04865829698754ec8c474
Autor:
Elena Maria Elli, Angelo Belotti, Andrea Aroldi, Matteo Parma, Pietro Pioltelli, Enrico Maria Pogliani
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 6, Iss 1, Pp e2014042-e2014042 (2014)
Deferasirox (DSX) is the principal option currently available for iron-chelation-therapy (ICT), principally in the management of myelodysplastic syndromes (MDS), while in primary myelofibrosis (PMF) the expertise is limited. We analyzed our experienc
Externí odkaz:
https://doaj.org/article/2dd99b1c30184f009aa9950a59c8cb92
Autor:
Giovanni Rindone, Andrea Aroldi, Elisa Bossi, Luisa Verga, Giovanni Zambrotta, Sara Tarantino, Rocco Piazza, Lara Mussolin, Roberto Chiarle, Carlo Gambacorti-Passerini
Publikováno v:
Blood Advances. 7:314-316
Autor:
Andrea Aroldi, Mario Mauri, Matteo Villa, Federica Malighetti, Federica Cocito, Claudia Voena, Roberto Chiarle, Luca Mologni, Rocco Piazza, Carlo Gambacorti-Passerini
Publikováno v:
Blood. 140:3136-3138
Publikováno v:
American Journal of Hematology. 97:1075-1085
TKI discontinuation proved to be safe and feasible in patients with CML with deep and durable molecular responses, introducing an additional treatment goal for these patients beyond overall survival. However, treatment interruption is a safe procedur
Autor:
Elisa Bergaggio, Wei-Tien Tai, Andrea Aroldi, Elisa Landoni, Manuel Nuesch, Ines Mota, Jasna Metovic, Leyuan Ma, Diego Alvarado, Chiara Ambrogio, Claudia Voena, Rafael Blasco, Tongqing Li, Daryl Klein, Darrell Irvine, Mauro Papotti, Barbara Savoldo, Gianpietro Dotti, Roberto Chiarle
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Francesco Boccalatte, Roberto Mina, Andrea Aroldi, Sarah Leone, Carter M. Suryadevara, Dimitris G. Placantonakis, Benedetto Bruno
Publikováno v:
Cancers. 14(20)
Chimeric antigen receptor (CAR) T cells in solid tumors have so far yielded limited results, in terms of therapeutic effects, as compared to the dramatic results observed for hematological malignancies. Many factors involve both the tumor cells and t